Anonymous
Guest
Anonymous
Guest
Would you leave a $125k/yr job (device) in a mid market city for a TM roll with Bard Vascular Access? Would appreciate any thoughtful responses.
Would you leave a $125k/yr job (device) in a mid market city for a TM roll with Bard Vascular Access? Would appreciate any thoughtful responses.
Bard Access sucks, and the best days are far behind. You will spend all your time selling the dog PIV product, port access needles, Site Scrub and bullshit kits of Statlock, all while protecting your PICC business and fielding calls about broken 3CG/sherlock and capital equipment every day. On top of that, you will have a micromanager up your ass twenty-four seven including weekends. You can make $125k pretty much doing anything nowadays. This is not worth it. Trust me.
OP here. I appreciate your feedback. I have talked with a local rep in my region/ same position, 2 reps back. And yes I know CP gets a lot of bs but I do know that it has the potential to provide some insight into arena's that not everyone may be familiar with. I have never sold vascular so it's all new to me. Thank you.
Is Statlock growing its revenue or losing ground? I have an opportunity with 3M and in the first interview, was told that bard Statlock owns this space in securement. Checked with two hospitals an they both use statlock. They are also evaluating a clip like device and said 3M is too many steps. Any info would be helpful
That is correct. BAS missed the boat many years ago regarding coating on piccs. They passed on Bioflo (mistake) and that coating is proving to be a big player. The navigation component is a big deal however not having a coating is locking BAS out of some accounts. It's hard for me to believe that accounts will pay a $20-$40 up charge for a coated picc line. More than likely BAS will be giving the coating away to protect their current accounts.
Angio does have Navigation. Its called Celerity.
Angio does have Navigation. Its called Celerity.
AD is clueless, Celerity is not a navigation device. it's a joke, vasanova holds more weight than that terrible product. nobody likes a follower, AD will never compete in this space. it will always be bard's market and arrow praying for a few big breaks.